Pharmacotherapy -- add-on therapies

September 2005
CMAJ: Canadian Medical Association Journal;9/13/2005 Supplement, Vol. 173, pS37
Academic Journal
The article focuses on the effectiveness regarding the use inhaled corticosteriods (ICS)and leukotriene receptor antagonists (LTRA)as add-on therapy in treating children with asthma. The effectiveness ICS has been compared with long-acting bronchodilators (LABA) such as salmenterol or formoterol. Implications of the research were also enumerated.


Related Articles

  • Antileukotrienes as Adjunctive Therapy in Acute Asthma. Kuitert, Lieske M. E.; Watson, Danie // Drugs;2007, Vol. 67 Issue 12, p1665 

    The leukotriene receptor antagonists (LTRAs) are a comparatively new class of asthma drugs that exhibit both bronchodilator and anti-inflammatory properties. There is a substantial body of evidence for their benefit in the management of chronic asthma in both adults and children, and...

  • Slowing the Deterioration of Asthma and Chronic Obstruction Pulmonary Disease Observed during Bronchodilator Therapy by Adding Inhaled Corticosteroids. Dompeling, Edward; van Schayck, Constant P.; van Grunsven, Petrus M.; van Herwaarden, Cees L. A.; Akkermans, Reinier; Molema, Johan; Folgering, Hans; van Weel, Chris // Annals of Internal Medicine;5/15/93, Vol. 118 Issue 10, p770 

    Presents a study which aimed to determine if deterioration in patients with asthma or chronic obstructive pulmonary disease during bronchodilator therapy could be slowed by additional treatment with an inhaled corticosteroid. Method of the study; Results and discussion; Conclusion.

  • The evidence based Management of Bronchiolitis. Ko, Hui-Ming; Chu, I-Wen // Internet Journal of Pediatrics & Neonatology;2009, Vol. 10 Issue 1, p14 

    Acute bronchiolitis is a common respiratory illness in children under 12 months of age. Although much is known about the pathological features and manifestations of bronchiolitis, the optimal treatment for this condition if still unavailable. Various treatment modalities have been championed...

  • Step-Down Therapy for Controlled Mild Persistent Asthma.  // Travel Medicine Advisor;Aug2007, Vol. 17 Issue 8, p16 

    The article discusses a study on the suggested treatment for persistent asthma. Low-dose inhaled corticosteroids (LDIC) is used as an initial maintenance therapy and is used as a step-down therapy in reducing the use of pharmacotherapy without increasing asthma symptomatology. It is recommended...

  • Guidelines for Asthma Management: A Review and Comparison of 5 Current Guidelines. Myers, Timothy R. // Respiratory Care;Jun2008, Vol. 53 Issue 6, p751 

    The first clinical practice guidelines for the assessment and management of asthma were published over 20 years ago in New Zealand and Australia. During the same period, British and Scottish groups were collaborating on a United Kingdom version of asthma guidelines. Shortly after the...

  • A comparative study of efficacy and safety of arformoterol and salbutamol nebulization as rescue therapy in acute non-severe asthma. Das, Sibes K.; Biswas, Indranil; Bandyopadhyay, Arun K.; Bairagya, Tapan D.; Bhattacharya, Somnath // Indian Journal of Pharmacology;Jul2011, Vol. 43 Issue 4, p463 

    Arformoterol, a long-acting beta-2 agonist, has a rapid onset and long duration of action. Its role as rescue medication in acute asthma attack is undetermined. To compare the efficacy and tolerability of arformoterol with salbutamol nebulization, a study was conducted among 50 patients with...

  • Considerations in the long-term management of asthma in ambulatory patients. Williams, Dennis M. // American Journal of Health-System Pharmacy;5/15/2006, Vol. 63 Issue 10, pS14 

    Purpose. The goals of treatment and drug therapies used for long-term asthma control, classification of the disease by severity, and treatment based on severity are reviewed, with an emphasis on recent controversies in treatment approach and safety concerns. Summary. Patient education and...

  • Breathe easier. Gordon, Mary Ebitt // Self;Apr97, Vol. 19 Issue 4, p95 

    Reports on the availability of leukotriene receptor antagonists or inhibitors, oral medications for asthma sufferers. Drugs in the category introduced in the market; Need for doctor's prescription on the kind of drug suited for severity of asthma.

  • New safety information on long-acting beta-2 agonists.  // WHO Drug Information;2005, Vol. 19 Issue 4, p289 

    The article provides information pertaining to the increased risk of asthma-related deaths associated with long-acting beta-2 agonists. Such medications involved in the prevention of the asthma include salmeterol, formoterol, and two combination products containing salmeterol or formoterol in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics